Por: RTTNews Health January 08, 2024
Evotec SE (EVO) announced progress within the strategic partnership with Bristol Myers Squibb. Evotec received a $25 million payment to progress further research. A first programme, EVT8683, was in-licensed by Bristol Myers Squibb in September 2021 as BMS-986419. A Phase II study for BMS-986419 is scheduled to commence in 2024. The companies entered their strategic neuroscience collaboration in December 2016. In March 2023, the companies... + full article
Fox Business USA Business December 26, 2023
Check out what's clicking on FoxBusiness.com Bristol Myers Squibb said on Tuesday it would to bolster its cancer drug business, marking the second large deal struck by the drugmaker in less than a week. With the deal, Bristol will gain access to RayzeBio's late-stage... + más
High school scores and top performers from Friday, March 24 | Orlando Sentinel
Bristol Myers to buy Karuna Therapeutics for $14B | Fox Business
Fox Business USA Business December 22, 2023
Check out what's clicking on FoxBusiness.com Drugmaker to buy neuroscience-drug developer Karuna Therapeutics for $14 billion. Under the terms, Bristol would pay $330 a share in cash for Karuna and its experimental schizophrenia drug now up for U.S. government approval.... + más
A New Drug Compound Shows Promise for Schizophrenia | Time
RTTNews USA Health December 11, 2023
Agenus Inc. () said it has triggered the second development milestone payment under global licensing agreement with Bristol Myers Squibb for BMS-986442. Agenus will receive a $25 million cash payment from Bristol Myers Squibb with the dosing of the first patient in the phase 2... + más
Bristol Myers Squibb to buy cancer drugmaker Mirati Therapeutics in up to $5.8B deal | Fox Business
'The Bachelor' season 27 cast revealed: Meet the ladies vying for Zach Shallcross' heart | ABC News
RTTNews USA Health November 07, 2023
Evotec SE (EVO) and Dewpoint Therapeutics announced a R&D collaboration to advance Dewpoint's oncology pipeline programmes of condensate modifying therapeutics to Investigational New Drug Applications using Evotec's data-driven platform. Evotec will facilitate the... + más
'Frustration' fuels Broncos' sideline blowup in loss | ESPN
Did Martha Washington really name a cat after Alexander Hamilton? | The Boston Globe
Fox Business USA Business October 10, 2023
FOX Business' Lydia Hu has the latest on the backbone of oncology treatment on 'The Big Money Show.' Bristol Myers Squibb said Sunday it will acquire drugmaker Mirati Therapeutics in a deal worth up to $5.8 billion, adding to its oncology business portfolio. The... + más
Tottenham owner Joe Lewis charged with insider trading in New York | ABC News
Billionaire Joe Lewis has been arrested for alleged insider trading, with prosecutors saying he helped personal pilots, assistants, and romantic partners make 'millions' | Business Insider
Orlando Sentinel USA Entertainment April 17, 2023
In the first week of a new TV season, football was the top draw in prime time and a huge driver of viewers. The NFL provided the most-watched telecast on Sunday and Thursday. CBS’ NFL coverage on Sunday – which started outside prime time -- averaged 20.7 million viewers in... + más
Forbes USA Life March 26, 2023
Le Bristol Paris is making waves in the metaverse.Le Bristol A couple of years shy of its centenary, Paris’ Le Bristol hotel is making its web3 debut with the launch of Le Bristol Unlocked, 11 exclusive NFTs (the number corresponds to the hotel’s 11 signature suites) which... + más
NFL Playoff Scenarios | ABC News
Council Post: Web 3.0 And The Metaverse In 2023 | Forbes
About iurex | Privacy Policy | Disclaimer |